These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3373416)

  • 1. Pharmacokinetic model equations for the one- and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal.
    Wijnand HP
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):109-28. PubMed ID: 3373416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequence of equal absorption, distribution and/or elimination rate constants.
    Plusquellec Y; Courbon F; Nogarede S
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):197-203. PubMed ID: 10716057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculating the hybrid (macro) rate constants of a three-compartment mamillary pharmacokinetic model from known micro-rate constants.
    Upton RN
    J Pharmacol Toxicol Methods; 2004; 49(1):65-8. PubMed ID: 14670695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphical approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Macheras PE
    J Pharm Sci; 1985 May; 74(5):582-4. PubMed ID: 4020640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Bialer M
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):111-3. PubMed ID: 7381690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique pharmacokinetic characteristics of the one-compartment first-order absorption model with equal absorption and elimination rate constants.
    Zhi JG
    J Pharm Sci; 1990 Jul; 79(7):652-4. PubMed ID: 2398478
    [No Abstract]   [Full Text] [Related]  

  • 7. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of absorption rate data for inhaled fluticasone propionate obtained in compartmental pharmacokinetic modeling.
    Krishnaswami S; Hochhaus G; Möllmann H; Barth J; Derendorf H
    Int J Clin Pharmacol Ther; 2005 Mar; 43(3):117-22. PubMed ID: 15792395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption.
    Purves RD
    J Pharmacokinet Biopharm; 1996 Feb; 24(1):79-101. PubMed ID: 8827584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of plasma concentration-time curves after oral dosing.
    Ronfeld RA; Benet LZ
    J Pharm Sci; 1977 Feb; 66(2):178-80. PubMed ID: 839412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination.
    Garrett ER
    J Pharmacokinet Biopharm; 1994 Apr; 22(2):103-28. PubMed ID: 7815308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A simple method for predicting equality of absorption and elimination rate constants].
    Li JW; Zhang CL
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):392-4. PubMed ID: 2130592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlinear regression approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes.
    Chan KK; Miller KW
    J Pharm Sci; 1983 May; 72(5):574-6. PubMed ID: 6864511
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the time needed to achieve steady state if absorption and elimination constants are equal.
    Singer J; Vereczkey L
    J Pharmacokinet Biopharm; 1999 Jun; 27(3):297-300. PubMed ID: 10728491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncompartmental analysis for a one-compartment model with equal absorption and elimination rate constants.
    Ko H; Caputo JF; Adams WJ
    Pharm Res; 1989 Aug; 6(8):731-3. PubMed ID: 2813267
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of methods for estimating the rate constant of a one-compartment absorption model when absorption and elimination rate constants are equal.
    Hoke JF; Ravis WR
    J Pharm Sci; 1992 Apr; 81(4):401-2. PubMed ID: 1501081
    [No Abstract]   [Full Text] [Related]  

  • 18. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically relevant one-compartment pharmacokinetic models for skin. 1. Development of models.
    McCarley KD; Bunge AL
    J Pharm Sci; 1998 Apr; 87(4):470-81. PubMed ID: 9548901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model.
    Nerella NG; Block LH; Noonan PK
    Pharm Res; 1993 Jul; 10(7):1031-6. PubMed ID: 8104333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.